We hypothesize that IGFBP7 may be related to the activation of the TGF-β pathway; TGF-β is often secreted by tumor cells in the tumor microenvironment to reshape the tumor microenvironment and immune response [39]. The gene discussed is TGFB1; the disease is neoplasm.